Timpani Capital Management LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 267 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
Timpani Capital Management LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$3,679,000
-49.2%
27,112
+2.7%
2.06%
-1.2%
Q3 2018$7,248,000
+21.2%
26,405
-8.5%
2.09%
+18.3%
Q2 2018$5,979,000
+62.3%
28,861
+29.4%
1.76%
+37.0%
Q1 2018$3,683,000
+19.9%
22,299
-0.6%
1.29%
+16.6%
Q4 2017$3,071,000
-35.8%
22,430
-36.1%
1.10%
-36.7%
Q3 2017$4,782,000
+25.3%
35,124
+11.7%
1.74%
+23.2%
Q2 2017$3,816,000
+138.9%
31,434
+108.3%
1.42%
+121.2%
Q1 2017$1,597,000
-36.9%
15,088
-39.4%
0.64%
-39.2%
Q4 2016$2,529,000
-65.4%
24,888
-65.2%
1.05%
-63.7%
Q3 2016$7,304,000
-9.2%
71,562
+6.1%
2.90%
-14.8%
Q2 2016$8,048,000
+11.5%
67,479
+0.1%
3.41%
+11.8%
Q1 2016$7,216,000
-2.4%
67,383
-1.1%
3.05%
+1.6%
Q4 2015$7,390,000
+174.9%
68,160
+117.1%
3.00%
+176.8%
Q3 2015$2,688,000
-63.5%
31,389
-57.0%
1.08%
-49.3%
Q2 2015$7,371,000
+9.7%
73,052
-16.2%
2.14%
+6.6%
Q1 2015$6,719,000
+41.7%
87,132
-2.2%
2.00%
+7.6%
Q4 2014$4,742,000
+143.3%
89,111
+114.9%
1.86%
+109.1%
Q3 2014$1,949,000
-71.6%
41,472
-62.4%
0.89%
-71.1%
Q2 2014$6,871,000
+7.1%
110,306
+15.7%
3.08%
-9.1%
Q1 2014$6,414,000
+23.2%
95,353
-3.6%
3.39%
+31.2%
Q4 2013$5,205,000
+53.0%
98,956
+25.9%
2.59%
+29.0%
Q3 2013$3,401,000
-15.6%
78,581
-27.1%
2.00%
-21.7%
Q2 2013$4,030,000107,7542.56%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders